Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled hyperosmolar agents for bronchiectasis.

P Wills1, M Greenstone

  • 1Hillingdon Hospital, Dept of Respiratory Medicine, Pield Heath Road, Uxbridge, Middlesex, UK, UB8 3NN. pjwills@doctors.org.uk

The Cochrane Database of Systematic Reviews
|April 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Best cost estimate of greenhouse gases.

Science (New York, N.Y.)·2017
Same author

CLIMATE ECONOMICS. Opportunities for advances in climate change economics.

Science (New York, N.Y.)·2016
Same author

The antibiofilm effects of Byotrol™ G32.

Journal of applied microbiology·2013
Same author

Profound hyponatraemia following a tramadol overdose.

QJM : monthly journal of the Association of Physicians·2012
Same author

Use of a screening tool for detection of sleep-disordered breathing.

The Journal of laryngology and otology·2009
Same author

Pigeon fanciers lung: a case report.

Cases journal·2008
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Inhaled dry powder mannitol significantly improves lung mucus clearance in bronchiectasis patients. Further research is needed to evaluate hypertonic saline and long-term effects.

Area of Science:

  • Respiratory Medicine
  • Pulmonology
  • Clinical Trials

Background:

  • Mucus retention is a key feature of bronchiectasis, leading to bacterial colonization and airway damage.
  • Neutrophilic response to bacteria fails to clear infection and may worsen lung injury.
  • Hypertonic saline and inhaled dry powder mannitol are potential treatments for mucus stasis.

Purpose of the Study:

  • To evaluate the efficacy of inhaled hyperosmolar substances for treating bronchiectasis.

Main Methods:

  • Searched the Cochrane Airways Group Specialised Register and contacted experts.
  • Included trials of hyperosmolar inhalation in non-cystic fibrosis bronchiectasis patients.
  • Two reviewers assessed study suitability; data collection and analysis were performed.

Related Experiment Videos

Main Results:

  • Two small studies (28 participants) met inclusion criteria.
  • Mannitol inhalation doubled tracheobronchial clearance in central and intermediate lung regions.
  • No adverse effects were reported; one study showed a favorable health status response.

Conclusions:

  • Dry powder mannitol enhances tracheobronchial clearance in bronchiectasis and other respiratory conditions.
  • Hypertonic saline's efficacy in bronchiectasis requires further study, though it benefits other conditions.
  • Future research should include health status, exacerbations, and adverse events in longer-term trials.